N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141715 |
| CAS No | NA |
| Mol.F. | C9H10N6O3 |
| Mol.Wt. | 250.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141716 |
| CAS No | NA |
| Mol.F. | C8H9N3O5 |
| Mol.Wt. | 227.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141717 |
| CAS No | NA |
| Mol.F. | C20H20N2O3 |
| Mol.Wt. | 336.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141718 |
| CAS No | NA |
| Mol.F. | C20H20N2O4 |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141719 |
| CAS No | NA |
| Mol.F. | C20H20N2O5 |
| Mol.Wt. | 368.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141720 |
| CAS No | NA |
| Mol.F. | C29H52N2O6 |
| Mol.Wt. | 524.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141721 |
| CAS No | NA |
| Mol.F. | C18H22N2O2 |
| Mol.Wt. | 298.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141722 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141723 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141724 |
| CAS No | NA |
| Mol.F. | C13H8N2O2S |
| Mol.Wt. | 256.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141725 |
| CAS No | NA |
| Mol.F. | C23H25N3O6 |
| Mol.Wt. | 439.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141726 |
| CAS No | 35784-01-1 |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141727 |
| CAS No | NA |
| Mol.F. | C16H21N3O4 |
| Mol.Wt. | 319.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141728 |
| CAS No | NA |
| Mol.F. | C22H26N6O5 |
| Mol.Wt. | 454.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141729 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141730 |
| CAS No | NA |
| Mol.F. | C15H24N4O3 |
| Mol.Wt. | 308.4 |
| INV STATUS | CUSTOM SYNTHESIS |